ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FERNANDO ORAMAS M.D

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 3593

$1.4M Total Retail Price of All Prescriptions

Rank: 62 out of 3593

767 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 28,706 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,234 1,168 1 1
OMEPRAZOLE 1,162 1,127 2 5
LISINOPRIL 923 841 3 2
AMLODIPINE BESYLATE 882 873 4 3
METOPROLOL SUCCINATE 740 715 5 19
ALPRAZOLAM 721 716 6 37
LEVOTHYROXINE SODIUM 715 708 7 4
ATENOLOL 636 619 8 11
METFORMIN HCL 608 571 9 6
METOPROLOL TARTRATE 526 497 10 8
BENICAR HCT 525 519 10 11 155
CLOPIDOGREL 509 489 12 30
RANITIDINE HCL 501 469 13 27
ALENDRONATE SODIUM 480 467 14 22
FENOFIBRATE 458 423 15 39
ZOLPIDEM TARTRATE 442 430 16 12
HYDROCHLOROTHIAZIDE 431 413 17 10
FUROSEMIDE 407 364 18 9
TEMAZEPAM 403 394 19 56
DOXAZOSIN MESYLATE 382 377 20 63
PLAVIX 381 360 21 42
FOLIC ACID 366 358 22 117
ATORVASTATIN CALCIUM 355 355 23 15
CARVEDILOL 352 333 24 23
LOVASTATIN 333 331 25 20
WARFARIN SODIUM 316 316 26 18
GABAPENTIN 299 265 27 16
ACTONEL 269 269 28 197
CLOTRIMAZOLE-BETAMETHASONE 263 230 29 94
MECLIZINE HCL 259 255 30 96
CRESTOR 249 242 31 21
VIAGRA 246 229 32 84
CLORAZEPATE DIPOTASSIUM 240 230 33 236
JANUVIA 240 231 33 81
LOSARTAN POTASSIUM 238 230 35 14
AVODART 235 235 36 180
FAMOTIDINE 226 223 37 70
PANTOPRAZOLE SODIUM 224 224 38 45
DIOVAN 222 208 39 46
BENICAR 220 209 40 131
GLIPIZIDE 214 203 41 40
DIGOXIN 209 197 42 58
PAROXETINE HCL 209 209 42 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 196 44 26
GLYBURIDE 202 183 R 45 55
CLONIDINE HCL 201 193 46 41
JANUMET 200 184 47 238
LORAZEPAM 200 193 47 98
CLONAZEPAM 191 172 49 164
ISOSORBIDE MONONITRATE ER 184 184 50 61
FINASTERIDE 184 184 50 79
ENALAPRIL MALEATE 183 167 52 38
TAMSULOSIN HCL 183 183 52 33
DIOVAN HCT 170 170 54 76
IBUPROFEN 161 149 55 43
GLIMEPIRIDE 156 140 56 44
CELEBREX 151 143 57 100
NATEGLINIDE 149 127 58 345
DONEPEZIL HCL 137 137 59 31
AZITHROMYCIN 135 132 60 34
AMLODIPINE BESYLATE-BENAZEPRIL 132 126 61 65
LOSARTAN-HYDROCHLOROTHIAZIDE 126 126 62 48
INSULIN SYRINGE 120 96 63 91
SERTRALINE HCL 119 100 64 28
ACTOS 115 115 65 133
LATANOPROST 113 113 66 195
NAPROXEN 106 105 67 68
VOLTAREN 101 98 68 85
OXYBUTYNIN CHLORIDE 99 99 69 104
GLYBURIDE-METFORMIN HCL 98 84 R 70 95
ESCITALOPRAM OXALATE 93 93 71 71
PROMETHAZINE-CODEINE 92 80 R 72 338
FLUTICASONE PROPIONATE 92 92 72 32
ALLOPURINOL 92 79 72 35
DICLOFENAC SODIUM 90 77 75 74
NAMENDA 90 90 75 50
BUMETANIDE 89 89 77 148
KETOCONAZOLE 87 86 78 118
NIFEDIPINE ER 86 68 79 75
CIALIS 86 78 79 176
CICLOPIROX 83 83 81 170
RAMIPRIL 82 72 82 92
BRIMONIDINE TARTRATE 82 82 82 381
CIPROFLOXACIN HCL 81 77 84 52
PEN NEEDLE 80 80 85 188
POTASSIUM CHLORIDE 78 66 86 24
MEGESTROL ACETATE 76 76 R 87 152
TRAMADOL HCL 76 60 87 17
TRIAMCINOLONE ACETONIDE 74 61 89 119
LANTUS 72 53 90 57
TIMOLOL MALEATE 69 69 91 295
ADVAIR DISKUS 69 69 91 47
AMMONIUM LACTATE 65 62 93 125
LYRICA 64 62 94 105
LANTUS SOLOSTAR 64 59 94 122
VERAPAMIL ER 63 63 96 99
CITALOPRAM HBR 63 53 96 25
BENAZEPRIL HCL 63 59 96 69
METOCLOPRAMIDE HCL 61 61 99 145
DORZOLAMIDE-TIMOLOL 60 60 100 415
PIOGLITAZONE HCL 60 60 R 100 310
PENTOXIFYLLINE 60 60 100 149
TERAZOSIN HCL 59 59 103 115
ATENOLOL-CHLORTHALIDONE 59 59 103 191
LANSOPRAZOLE 58 58 105 113
PREDNISONE 57 56 106 49
CARTIA XT 55 55 107 299
DILTIAZEM ER 55 43 107 194
VENTOLIN HFA 55 54 107 80
COMBIVENT 54 54 110 161
NOVOLOG MIX 70-30 54 54 110 283
NIFEDIAC CC 54 54 110 360
FLUOXETINE HCL 51 48 113 60
CILOSTAZOL 51 51 113 163
NEXIUM 50 50 115 36
MICARDIS 50 50 115 336
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.